KWILP
TEVA icon

Kiwi Wealth Investments Limited Partnership’s Teva Pharmaceuticals TEVA Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-74,859
Closed -$3.76M – 141
2016
Q2 		$3.76M Sell
74,859
-191,189
-72% -$10.2M 0.37% 75
2016
Q1 		$14.2M Buy
+266,048
New +$15.6M 1.46% 16

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's TEVA Position: Q3 2016 in Review

Kiwi Wealth Investments Limited Partnership sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 74,859 shares — an estimated $3.76M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in TEVA in Q1 2016 and held it in 2 quarters. The position peaked at $14.2M in Q1 2016. 796 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

  • Kiwi Wealth Investments Limited Partnership reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 74,859 Teva Pharmaceuticals shares in Q3 2016, an estimated $3.76M.
  • Kiwi Wealth Investments Limited Partnership first reported a position in Teva Pharmaceuticals in Q1 2016 and held it in 2 quarters.
  • Kiwi Wealth Investments Limited Partnership's Teva Pharmaceuticals position peaked at $14.2M in Q1 2016.
  • 796 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q3 2016, filed 8 Nov 2016.